Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate mofetil plus tacrolimus vs tacrolimus for idiopathic membranous glomerulonephritis
2008-001009-41Phase 4Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- May 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in idiopathic membranous glomerulonephritis (IMG) and nephrosis comparing Tacrolimus alone with Mycophenolate mofetil plus tacrolimus (2 arms). Primary endpoint: Prevention of relapse of proteinuria after tacrolimus withdrawal. Started May 2008; status: completed.
02
Drugs
mycophenolate mofetiltacrolimus
03
Conditions
idiopathic membranous glomerulonephritis (IMG)nephrosis
Beyond the preview
Go deeper on 2008-001009-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001009-41.